Philip Levy Ho
Affiliations: | Kelsey-Seybold Clinic/Baylor College of Medicine |
Google:
"Philip Ho"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kukreja JB, Porten S, Golla V, et al. (2017) Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. European Urology Focus |
Brooks M, Mo Q, Krasnow R, et al. (2016) Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget |
Parker WP, Ho PL, Boorjian SA, et al. (2016) The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy. World Journal of Urology |
Ho PL, Willis DL, Patil J, et al. (2015) Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urologic Oncology |
Taoka R, Williams SB, Ho PL, et al. (2015) In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 9: E109-13 |
Ho PL, Williams SB, Kamat AM. (2015) Immune therapies in non-muscle invasive bladder cancer. Current Treatment Options in Oncology. 16: 5 |
Kurtova AV, Xiao J, Mo Q, et al. (2015) Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature. 517: 209-13 |
Kurtova AV, Xiao J, Mo Q, et al. (2015) Abstract 5470: Blocking wound-induced tumor repopulation between chemotherapy cycles as a novel approach to abrogate chemoresistance Cancer Research. 75: 5470-5470 |
Ho PL, Kurtova A, Xiao J, et al. (2014) Abstract 1928: Reporter construct for functional and real-time evaluation of cytokeratin 14+ bladder cancer stem cells Cancer Research. 74: 1928-1928 |
Ho P, Willis D, Patil J, et al. (2014) MP55-20 OUTCOME OF PATIENTS WITH CLINICALLY NODE-POSITIVE BLADDER CANCER WHO UNDERGO CONSOLIDATIVE SURGERY AFTER PRE-OPERATIVE CHEMOTHERAPY: MD ANDERSON CANCER CENTER EXPERIENCE Journal of Urology. 191 |